TXMD - TherapeuticsMD Inc. (TXMD) CEO Hugh O'Dowd on Q4 2021 Results - Earnings Call Transcript

TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Conference Call March 10, 2022, 08:30 AM ET Company Participants Lisa Wilson - Investor Relations Hugh O’Dowd - Chief Executive Officer James D’Arecca - Chief Financial Officer Mark Glickman - Chief Business Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Douglas Tsao – H.C. Wainwright Presentation Operator 0:05 Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Fourth Quarter 2021 Financial Results conference call. Following prepared remarks from the company, we will open the call for questions. 0:18 I would now like to turn the call over to Investor Relations for TherapeuticsMD. Lisa Wilson. Lisa? Lisa Wilson 0:24 Thank you, operator. Good morning, everyone. And thank you for joining today to discuss our fourth quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing, its fourth quarter 2021 financial results. The press release and accompanying

For further details see:

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q4 2021 Results - Earnings Call Transcript